Prograf

In the US, Prograf (tacrolimus systemic) is a member of the drug class calcineurin inhibitors and is used to treat Organ Transplant - Rejection Prophylaxis and Organ Transplant - Rejection Reversal.

US matches:

• Prograf


• Prograf Capsules

UK matches:

• Prograf 0.5mg, 1mg, 5mg Hard Capsules (SPC)
• Prograf 5mg/ml Concentrate for Solution for Infusion (SPC)

Ingredient matches for Prograf

Tacrolimus

Tacrolimus is reported as an ingredient of Prograf in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Bosnia & Herzegowina


• Brazil


• Canada


• Chile


• China


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Egypt


• Finland


• France


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Indonesia


• Iraq


• Ireland


• Israel


• Italy


• Jordan


• Kuwait


• Lebanon


• Libya


• Malaysia


• Netherlands


• New Zealand


• Norway


• Oman


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sudan


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Tunisia


• Turkey


• United Arab Emirates


• United States


• Venezuela


• Yemen

Tacrolimus monohydrate (a derivative of Tacrolimus) is reported as an ingredient of Prograf in the following countries:

• Austria


• Colombia


• Costa Rica


• Dominican Republic


• El Salvador


• Guatemala


• Honduras


• Japan


• Mexico


• Nicaragua


• Panama


• Sweden


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.